SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-13-004511
Filing Date
2013-09-25
Accepted
2013-09-25 06:02:49
Documents
3
Period of Report
2013-09-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 OPEXA THERAPEUTICS, INC. 8-K a50716091.htm 8-K 24969
2 EXHIBIT 10.1 a50716091ex10_1.htm EX-10.1 25927
3 EXHIBIT 99.1 a50716091ex99_1.htm EX-99.1 11607
  Complete submission text file 0001157523-13-004511.txt   64084
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 131113338
SIC: 2834 Pharmaceutical Preparations